Adalimumab in Treating Refractory Livedoid Vasculopathy

Livedoid vasculopathy is a chronic, recurrent skin disorder. It seriously affects the quality of patients’ life. However, the pathogenesis has not been fully identified yet. Here, this retrospective study describes the successful use of anti-TNF-α agent adalimumab in three cases of refractory livedo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xiao-Wen Huang, Huan-Xin Zheng, Meng-Lei Wang, Wan-Mei He, Mei-Xin Feng, Kang Zeng, Li Li
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-04-01
Col·lecció:	Vaccines
Matèries:	livedoid vasculopathy adalimumab anti-TNF-α agent
Accés en línia:	https://www.mdpi.com/2076-393X/10/4/549
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!